1. Home
  2. PRSO vs VRAX Comparison

PRSO vs VRAX Comparison

Compare PRSO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRSO
  • VRAX
  • Stock Information
  • Founded
  • PRSO 2008
  • VRAX 2013
  • Country
  • PRSO United States
  • VRAX United Kingdom
  • Employees
  • PRSO N/A
  • VRAX N/A
  • Industry
  • PRSO Semiconductors
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PRSO Technology
  • VRAX Health Care
  • Exchange
  • PRSO Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • PRSO 4.3M
  • VRAX 4.7M
  • IPO Year
  • PRSO 2001
  • VRAX 2022
  • Fundamental
  • Price
  • PRSO $0.96
  • VRAX $1.00
  • Analyst Decision
  • PRSO Strong Buy
  • VRAX Strong Buy
  • Analyst Count
  • PRSO 2
  • VRAX 1
  • Target Price
  • PRSO $3.38
  • VRAX $3.00
  • AVG Volume (30 Days)
  • PRSO 196.1K
  • VRAX 63.6K
  • Earning Date
  • PRSO 05-12-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • PRSO N/A
  • VRAX N/A
  • EPS Growth
  • PRSO N/A
  • VRAX N/A
  • EPS
  • PRSO N/A
  • VRAX N/A
  • Revenue
  • PRSO $15,626,000.00
  • VRAX $84,872.00
  • Revenue This Year
  • PRSO $3.96
  • VRAX $5,169.18
  • Revenue Next Year
  • PRSO $36.80
  • VRAX $66.97
  • P/E Ratio
  • PRSO N/A
  • VRAX N/A
  • Revenue Growth
  • PRSO 35.50
  • VRAX 7.03
  • 52 Week Low
  • PRSO $0.52
  • VRAX $0.82
  • 52 Week High
  • PRSO $2.34
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • PRSO 53.21
  • VRAX 40.68
  • Support Level
  • PRSO $0.86
  • VRAX $0.93
  • Resistance Level
  • PRSO $1.03
  • VRAX $1.13
  • Average True Range (ATR)
  • PRSO 0.08
  • VRAX 0.08
  • MACD
  • PRSO -0.00
  • VRAX -0.01
  • Stochastic Oscillator
  • PRSO 44.60
  • VRAX 12.73

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: